SCHEMBL6531724

SCHEMBL6531724

CS(=O)(=O)N(CCn1cc(-c2cccc(-c3ccc(F)cc3)c2)c(OCc2ccccc2)n1)S(C)(=O)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.43
MGLL Q99685 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.36
DHODH Q02127 1/20 0.36
CYP19A1 P11511 2/20 0.35
PTGER4 P35408 2/20 0.35
PTGER3 P43115 2/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
AGXT P21549 1/20 0.34
CYP3A4 P08684 1/20 0.34
PDE10A Q9Y233 1/20 0.34
PTGER1 P34995 3/20 0.34
TP53 P04637 1/20 0.33
MDM2 Q00987 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792220 0.93 PTGS2 (0.48) PTGS2MEN1ALDH1A1CYP1A2CASP1
SCHEMBL1384544 0.88 MGLL (0.41) PTGS2MGLLMRGPRX4DHODHPTGER4
SCHEMBL6531889 0.83 CYP19A1 (0.44) PTGS2CYP19A1MEN1ALDH1A1KMT2A
SCHEMBL1386510 0.81 AURKA (0.39) PTGER4PTGER3CYP1A2PDE10A
SCHEMBL1386167 0.80 PTGS2 (0.43) PTGS2MGLLMEN1ALDH1A1CYP1A2
SCHEMBL1385049 0.73 PDE10A (0.43) CYP1A2PDE10A
SCHEMBL1384073 0.73 CNR2 (0.47) ALDH1A1PDE10ATP53
SCHEMBL1386325 0.73 GABRG2 (0.42) MEN1ALDH1A1KMT2APDE10APTGER1
SCHEMBL2584626 0.73 MAOB (0.40) CYP19A1CYP1A2PDE10A
Hydrochloric Acid SCHEMBL2577843 0.72 PDE10A (0.42) CYP1A2PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005051917-A9 PYRAZOLYL DERIVATIVES IN THE FORM OF DRUGS FOR TREATING ACUTE OR CHRONIC NEURONAL REGRESSIONS AVENTIS PHARMA SA (FR) 2005-09-29 WO disclosed